Search
for
Sort by
Research 91–120 of 786
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Baricitinib: A Review in Severe Alopecia Areata
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Advances in the mechanism and new therapies of alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Baricitinib for the Treatment of Alopecia Areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Ruxolitinib found to cause eyelash growth: a case report
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Myeloproliferative disorder associated with alopecia universalis
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease